ABSTRACT
This article challenges accounts of metabolic disease and changes in body weight that begin and end with clinical outcomes, individual choice, or behavioural failure. It introduces the Metabolic Ambush as a condition in which much of the biological, material, and social history producing an outcome has already taken effect by the time that outcome becomes clinically visible. Insulin resistance is treated as a multi-organ metabolic node without being elevated into a universal cause. Obesity is recognised as a real phenotype and a possible causal mediator, but not as an adequate explanation of its own production.
The clinical efficacy of GLP-1-based pharmacotherapies is explicitly acknowledged. Their effects demonstrate that hunger, satiety, reward, and eating behaviour are not products of will alone. Yet pharmacological intervention does not, by itself, alter food prices, product formulation, unequal access, or the social sources of chronic stress. Agency is retained, but distinguished from authorship of the world in which action takes place.
Loading comments…